|
Match
|
Document |
Document Title |
|
|
5470880 |
Method of using citric acid for the treatment of wrinkles
A method for visibly reducing a skin wrinkle by topically applying to the wrinkle citric acid or a topically salt thereof.
|
|
|
5464869 |
Use of dimercaptan acids, salts and metabolites thereof as antiretroviral treatments
A method for the prophylaxis or treatment of retroviruses in warm-blooded animals comprising administering to said warm-blooded animal a therapeutically effective amount of a dimercaptan acid,...
|
|
|
5447918 |
Gastrointestinal anti-irritant composition comprising sucralfate and methods of use
A composition comprising sucralfate and one or more anti-acid epigastralgic relieving agents in a weight ratio of between 0.5:1.0 to 1.3 sucralfate to anti-acid epigastralgic relieving agent and a...
|
|
|
5444090 |
Method of reducing the rate of hair growth
The rate and character of mammalian hair growth is altered by the topical application to the skin of a composition containing an organic inhibitor of the enzyme L-asparagine synthetase.
|
|
|
5434187 |
Eye drops
Adding an aliphatic dicarboxylic acid or a salt thereof with an inorganic base to a conventional eye drop solution has been found to extend the dwell time of the solution when applied to the...
|
|
|
5432200 |
Method for increasing urinary excretion of electrolytes
A method for supplementing dietary potassium, magnesium and citrate is disclosed that comprises orally administering an effective amount of potassium magnesium citrate in a single salt. Methods for...
|
|
|
5425938 |
Polyamino salts of alpha-hydroxyacids, alpha-ketoacids and related compounds
Cosmetic compositions are described wherein α-hydroxyacids, α-ketoacids and related compounds are formed into amine salts through neutralization with a multi-amine functionalized polymer....
|
|
|
5411991 |
Method of reducing hair growth employing sulfhydryl active compounds
A method of reducing the rate of mammalian hair growth includes topically applying a composition containing a sulfhydryl reactive compound to the skin.
|
|
|
5405620 |
Pharmaceutical composition for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or tumorous origin
The pharmaceutical composition according to the invention consists essentially of: i) one or more, pharmaceutically acceptable, water soluble compounds of boron, fluorine, magnesium, vanadium,...
|
|
|
5385943 |
Use of topically applicable preparations for treatment of presbyderma
The invention relates to the use of topically applicable preparations containing alpha,omega-n-alkanedicarboxylic acids with 7 to 13 carbon atoms, their physiologically compatible salts or their...
|
|
|
5373023 |
Tetrahydronaphtalene derivatives, their preparation and pharmaceutical compositions containing them
The invention provides compounds which are tetrahydronaphthalene derivatives of the formula (I) ##STR1## wherein R 1 represents a halogen atom, a cyano group, a nitro group, an unbranched (C 1 -C...
|
|
|
5354565 |
Biocide activator
A biocide composition comprising (A) 1 to 50% by weight of a biocide, and (B) 0.005-60% by weight of a biocide activator having the specific formula is provided. The biocide effect of a...
|
|
|
5322857 |
Food products having increased potassium content and use thereof in enhancing gastric acid response
Coffee products and other comestibles having an increased content of potassium are useful to enhance the gastric acid response of persons having abnormally low gastric acid secretion such as...
|
|
|
5322856 |
Fortified glutaraldehyde chemical sterilant/disinfectant
A fortified glutaraldehyde compound with and without dual synergistic phenols is provided for disinfection and sanitization. One formula consists of: glutaraldehyde; dual quaternary ammonium...
|
|
|
5314919 |
Calcium supplements
A calcium citrate malate complex or mixture having a molar composition of calcium:citrate:malate of about 6:2:3. The calcium citrate malate is preferably administered in an oral dosage form,...
|
|
|
5310768 |
Method for improving the glutamine content in skeletal muscle and composition therefore
A method of treatment of postoperative and posttraumatic patients for improving the glutamine content in skeletal muscle by administrating alpha-ketoglutarate; also, a composition for carrying out...
|
|
|
5310758 |
Bathing preparation
Bathing preparations comprising a soluble aluminum carboxylate exhibit excellent dissolvability into bath water.
|
|
|
5296241 |
Therapeutic composition and method of using same for treatment of hangover
A therapeutic composition for treating the manifestations of overindulgence in alcohol includes effective amounts of acetaminophen, one or more antacids agents and caffeine, all provided in finely...
|
|
|
5296476 |
Skin care compositions
The present invention relates to a topical skin care formulation comprised of micronized calcium citrate and salicylic acid. This composition provides a method for treating acne as well as...
|
|
|
5294641 |
Method for treating a medical patient for cardiac trauma
A method for treating a medical patient prior to or during heart trauma, e.g., myocardial infarction, angina and ischemia. An effective dosage of pyruvate is introduced into the patient to increase...
|
|
|
5290572 |
Opthalmic composition for treating dry eye
An ophthalmologic composition therapeutic in the treatment of dry eye syndrome is disclosed. The composition is comprised of a minimally soluble salt of calcium that has been finely divided into...
|
|
|
5272166 |
Method for selective reduction of Lp(a)
The present invention relates to methods and corresponding agents for lowering plasma Lp(a) levels by the administration of agents that reduce Lp(a) and selectively separate therefrom the apo(a)...
|
|
|
5272177 |
Use of sebacic acid and derivatives thereof in enteral and parenteral nutrition and pharmaceutical compositions containing said compounds
Sebacic acid and the pharmacologically acceptable derivatives thereof, such as the novel compounds sodium sebacate and potassium sebacate, the sebacic acid triglyceride and the sodium and potassium...
|
|
|
5264455 |
Sulfur-substituted mevinic acid derivatives
|
|
|
5252606 |
Fortified glutaraldehyde disinfectant
A highly fortified glutaraldehyde formulation is provided consisting of guaternary ammonium chloride; glutaraldehyde; para tertiary amylphenol; citric acid, isopropyl alcohol, and water to form a...
|
|
|
5223271 |
Lithium treatment
The present invention provides a method of treatment and/or prophylaxis of the human or animal body to combat Molluscum Contagiosum, said treatment comprising topically administering a...
|
|
|
5219889 |
Dietary supplementation with potassium magnesium citrate
A method for supplementing dietary potassium, magnesium and citrate is disclosed that comprises orally administering an effective amount of potassium magnesium citrate in a single salt. Methods for...
|
|
|
5213838 |
Sodium-free salt substitute containing citrates and method for producing the same
A sodium-free composition suitable for use as a substitute for common table salts and a method for preparing the same. The sodium-free composition has as its primary components potassium citrates,...
|
|
|
5211947 |
Method for lowering blood cholesterol levels with granulocyte-macrophage colony stimulating factor
A method for lowering the blood cholesterol levels in mammals and humans by administering GM-CSF is disclosed.
|
|
|
5204331 |
Composition for debridement of retained lens materials
A composition for debridement of retained lens materials is disclosed. The composition comprises a viscoelastic material and ethylenediaminetetraacetic acid or salts thereof dissolved in a...
|
|
|
5186946 |
Disinfectant with wide spectrum germicidal activity
A disinfectant effective against substantially all bacteria, fungi, bacterial and fungal spores, and viruses. The disinfectant composition consists of: from 60 to 90% by weight of potassium...
|
|
|
5154932 |
Antimicrobial positively charged particles
Formulations or products are caused to be active antimicrobials by the addition thereto of at least one effective amount of at least one crystalline mixed metal hydroxide (MMOH) conforming...
|
|
|
5145686 |
Topical pharmaceutical compositions
Topical pharmaceutical compositions for the treatment of lesions of the skin or mucous membranes containing a physiologically acceptable lithium salt together with at least one substance selected...
|
|
|
5139788 |
Noncontaminating antimicrobial composition
An antimicrobial surface sanitizing composition comprising a major portion of diluent and an active antimicrobial agent, said agent comprising an antimicrobial effective amount of an alpha-hydroxy...
|
|
|
5128151 |
Stabilized menadione bisulfite formulations and their preparation
Powdered and/or granulated menadione sodium bisulfite formulations additionally contain a physiologically tolerated organic or inorganic acid. The novel formulations possess good water solubility...
|
|
|
5128374 |
Use of calcium citrate malate for the treatment of osteoporosis and related disorders
Methods for building bone in a human or other animal subject, comprising administering to said subject a safe and effective amount of calcium citrate malate. The calcium citrate malate is...
|
|
|
5122540 |
Method and composition for treating warts and throat soreness with DMSO and citric acid
A solution of DMSO and a body reactive agent (such as citric acid) is provided, and is typically topically applied to the body, as to a wart or to the skin of the throat.
|
|
|
5104898 |
Method of preventing graft rejection in solid organ transplantation
A method is disclosed for preventing graft rejection of transplanted solid organs, in mammal recipients thereof, by administering an effective graft rejection preventative amount of succinylacetone...
|
|
|
5100646 |
NMR glomerular filtration test
A method of determining the glomerular filtration rate of a subject comprises (1) obtaining a serum sample S pre and a urine sample U pre from a subject; (2) administering to the subject an...
|
|
|
5081151 |
Method of growing hair
A method for inducing, maintaining or increasing hair growth which is achieved by topically applying a preserved composition to mammalian skin and hair in a mammal having need thereof, the...
|
|
|
5075336 |
Alkaline earth metal salts of oxa polyacid compounds
Compounds of general formula ##STR1## in which: M is an alkaline earth metal, R 1 , R 2 , R 3 , R 4 , R 5 and i being defined in the description. Medicaments.
|
|
|
5071874 |
L-carnitine magnesium citrate
L-carnitine magnesium citrate and a process for its production, starting from a magnesium compound, citric acid and L-carnitine, as well as the use of the product as a combination preparation in...
|
|
|
5064636 |
Paramagnetic oil emulsions as enteric MRI contrast agents
A paramagnetic oil emulsion for enteric administration composed of about 5 to about 30 volume percent oil and about 70 to about 95 volume percent aqueous-based paramagnetic carrier, the...
|
|
|
5043357 |
Virucidal agent having broad-spectrum activity
A virucidal agent having broad-spectrum activity contains at least 70% by weight of ethanol and/or propanols and from 0.5 to 5% by weight of a short-chain organic acid.
|
|
|
5032615 |
Continuous hemodialysis using citrate
The present invention provides a method of preventing blood from clotting in a filter during continuous arteriovenous or venovenous hemodialysis on a patient comprising administering to the blood...
|
|
|
5025037 |
Uses for the oral use of oak poison preventative in the treatment of: feline leukemia, increased wool production in sheep, and reduction of shipping fever in stressed animals
New uses for the Oak Poison Preventive supplement, including the treatment of feline leukemia, shipping fever in cattle, and increased wool production in sheep.
|
|
|
5021455 |
Solution for neutralizing caustic effects of alkaline cementitious materials on human skin
An aqueous solution containing a mild concentration of organic acids, vitamin E acetate and a low concentration of aromatic oil to neutralize the caustic effects of alkaline cementitious materials...
|
|
|
5010103 |
Compositions and methods comprising 2-mercaptomethylglutaric acid derivatives
New compounds having utility for enhancing the activity of antifolates are disclosed of the formula: ##STR1## wherein X is selected from hydrogen ##STR2## and R" ; R' is selected from alkyl,...
|
|
|
5006551 |
Composition for destroying malignant tumors
An agent having a destructive effect on malignant tumors and containing as active substances alpha-ketoglutaric acid and 5-hydroxymethylfurfural is described. The agent can be used in cancer...
|
|
|
4996232 |
Reducing bacterial content in water
The invention provides dry compositions which when dissolved in water exhibit unexpectedly high antibacterial activity. The compositions comprise at least two of the following ingredients (a) to...
|